Livzon Pharmaceutical repurchases A-shares on September 8

Livzon Pharmaceutical Group repurchased 72,700 A-shares on September 8, 2025, through the Shenzhen Stock Exchange. The repurchases were executed at prices ranging from 40.98 yuan to 41.64 yuan per share, totaling 2,999,492 yuan. These shares, once repurchased, are intended for cancellation.

This recent activity follows a series of A-share buybacks initiated on December 25, 2024, continuing through September 2025. The total number of repurchased shares yet to be canceled stands at 72,700, reflecting the company’s ongoing share repurchase program. The company confirmed that these transactions comply with relevant listing rules and regulatory requirements.